SpectraCell Laboratories | Online Library-LPP Small dense LDL-Abstract

Now Offering COVID-19 PCR and Antibody Testing. Learn More

Online Library-LPP Small dense LDL-Abstract

Small - Dense LDL

Click Here for Clinical Update (1)

NCEP risk factor - Small dense LDL - image  Click here to download brochure. 

2011 IUBMB Life

Ubiquinol-induced gene expression signatures are translated into altered parameters of erythropoiesis and reduced low density lipoprotein cholesterol levels in humans.

2011 J Clin Lipidol

Clinical Utility of Inflammatory Markers and Advanced Lipoprotein Testing: Advice from an Expert Panel of Lipid Specialists.

2011 J Nutr

Algal docosahexaenoic Acid affects plasma lipoprotein particle size distribution in overweight and obese adults.

2010 J Lipid Res

Changes in lipoprotein(a), oxidized phospholipids and LDL subclasses with a low-fat, high-carbohydrate diet.

FREE FULL TEXT 

2011 Lipids Health Dis

Small dense LDL particles--a predictor of coronary artery disease evaluated by invasive and CT-based techniques: a case-control study.

FREE FULL TEXT 

2011 Obesity

Amelioration of Lipid Abnormalities by α-Lipoic acid Through Antioxidative and Anti-Inflammatory Effects. 

2009 Atherosclerosis

Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis.

2009 Atherosclerosis

Small dense low-density lipoprotein in familial combined hyperlipidemia: independent of metabolic syndrome and related to history of cardiovascular events. 

2009 Metabolism

Effect of L-carnitine on the size of low-density lipoprotein particles in type 2 diabetes mellitus patients treated with simvastatin.

2008 Arterioscler Thromb Vasc Biol

Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis.

FREE FULL TEXT

2008 Clin Chim Acta

Small dense LDL particles and metabolic syndrome in a sample of middle-aged women.  Findings from Progetto Atena.

2008 Diabetes Care

Lipoprotein management in patients with cardiometabolic risk - Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation

FREE FULL TEXT

2008 J Nutr Sci Vitaminol

Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome.

FREE FULL TEXT 

2007 Am J Clin Nutr

Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men.

2007 Am J Clin Nutr

Fructose intake is a predictor of LDL particle size in overweight schoolchildren 

2007 Diabetes Care

Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles and c-reactive protein in metabolic syndrome

FREE FULL TEXT

2006 Eur J Intern Med

Low-density lipoprotein size and cardiovascular prevention. 

2006 Curr Opin Lipidol

Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease. 

2006 QJM

Low-density lipoprotein size and cardiovascular risk assessment.

FREE FULL TEXT

2005 Arterioscler Thromb Vasc Biol

Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study.

FREE FULL TEXT 

2005 Clin Chem

Distribution of LDL particle size in a population-based sample of children and adolescents and relationship with other cardiovascular risk factors.

FREE FULL TEXT 

2005 The Standard

Managing lipoprotein dyslipidemias through lifestyle and nutraceutical therapies

FREE FULL TEXT 

2004 J Nutr

The effect of dietary fat on LDL size is influenced by apolipoprotein E genotype in healthy subjects.

FREE FULL TEXT

2004 Metabolism

Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia. 

2002 J Lab Med

Why cholesterol measurements may be misleading about lipoprotein levels and cardiovascular disease risk - clinical implications of lipoprotein quantification using NMR spectroscopy.

2000 Am J Clin Nutr

Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.

FREE FULL TEXT 

1996 JAMA

Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.